Innovating Works
AiPSC: AI-powered platform for autologous iPSC manufacturing MIDA BIOTECH BV processed a HORIZON EUROPE HORIZON-EIC-2021-PATHFINDERCHALLENGES-01 Induced pluripotent stem cell (iPSCs) can be differentiated into any cell type of the body and transplanted without rejection. The potential...
2022-09-01 - 2026-08-31 | financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.